Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
$ 7.11MStock Based Compensation
VS
Market
Sector
Industry
History
$ 101.52Close
$ 11.15 - $ 116.15 52-Week Range
Ticker Information
Ticker
CDTXCompany Name
CIDARA THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQCIDARA THERAPEUTICS INC - Stock Based Compensation Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
CDTX - SB Comp. Historical data
| Date | Stock Based Compensation |
|---|---|
| 6/30/2025 | $ 7.11M |
| 3/31/2025 | $ 4.85M |
| 12/31/2024 | $ 3.91M |
| 9/30/2024 | $ 3.08M |
| 6/30/2024 | $ 3.12M |
| 3/31/2024 | $ 3.22M |
| 12/31/2023 | $ 3.06M |
| 9/30/2023 | $ 2.9M |
| 6/30/2023 | $ 2.95M |
| 3/31/2023 | $ 2.83M |
Key Performance Insights, Last 5 Years
- CIDARA THERAPEUTICS INC's latest trailing twelve months (TTM) SB Comp. stands at $ 4.27M.
- Over the past 5 years, CIDARA THERAPEUTICS INC's average SB Comp. has been $ 3.84M.
- The median SB Comp. for CIDARA THERAPEUTICS INC during this period was $ 3.66M
- CIDARA THERAPEUTICS INC reached its highest SB Comp. over the past 5 years at $ 7.11M.
- The lowest SB Comp. recorded by CIDARA THERAPEUTICS INC in the same timeframe $ 2.83M
Similar metrics to SB Comp.:
- Stock Based Compensation Margin - [Calculation] The company’s stock-based compensation [SbComp] expressed as a percentage of [Revenue].
- Depreciation, Amortization & Accretion - [Cash Flow Statement] A component of operating cash flow [NCFO] representing the aggregate net amount of depreciation, amortization, and accretion recognized during an accounting period. As a non-cash item, the net amount is added back to net income when calculating cash provided by operations.
- Capital Expenditures Coverage - [Calculation] The Capital Expenditure Ratio, or capex coverage, describes the ability of a business to generate enough cash from day-to-day operations to cover capital expenditures. It is calculated by dividing the cash flow from operations [NCFO] by its capital expenditures [CapEx].
Definition of Stock Based Compensation
[Cash Flow Statement] Stock Based Compensation, also called Share Based Compensation or Equity Compensation, is a method of paying directors, executives and employees with equity in the business. As non-cash expense, this element is added back when calculating net cash generated by operating activities [NCFO].CDTX - Stock Based Compensation, Last 5 years
$ 2.83M
Minimum
Mar 31, 2023
$ 7.11M
Maximum
Jun 30, 2025
$ 3.84M
Average
$ 3.66M
Median
SB Comp. Benchmark AnalysisMarket
The chart above depicts the distribution of SB Comp. for companies in the Total Stock Market. The average SB Comp. of the companies is $ 12.12M with a standard deviation of $ 14.36M.
The following table provides additional summary stats:
SB Comp. in the Market:
| filtered constituents | 3.52K |
|---|---|
| min | $ -20.28M |
| max | $ 59.14M |
| average | $ 12.12M |
| median | $ 6.33M |
| std | $ 14.36M |